The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis (Q38055449)

27 August 2017

The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis (English)

1 reference

27 August 2017

1 reference

0 references

Wiebke Janssen

1

1 reference

27 August 2017

Soni Savai Pullamsetti

2

1 reference

27 August 2017

John Cooke

3

1 reference

27 August 2017

Norbert Weissmann

4

1 reference

27 August 2017

Andreas Guenther

5

1 reference

27 August 2017

Ralph Theo Schermuly

6

1 reference

27 August 2017

1 January 2013

1 reference

27 August 2017

1 reference

27 August 2017

229

1 reference

27 August 2017

2

1 reference

27 August 2017

242-249

1 reference

Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland

27 August 2017

1 reference

21 January 2018

1 reference

Idiopathic pulmonary fibrosis

21 January 2018

1 reference

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

21 January 2018

1 reference

Mechanisms of pulmonary fibrosis

21 January 2018

1 reference

Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis

21 January 2018

1 reference

Epithelial stress and apoptosis underlie Hermansky-Pudlak syndrome-associated interstitial pneumonia

21 January 2018

1 reference

Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification

21 January 2018

1 reference

Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality

21 January 2018

1 reference

Pirfenidone in idiopathic pulmonary fibrosis

21 January 2018

1 reference

Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis

21 January 2018

1 reference

Antifibrotic activities of pirfenidone in animal models

21 January 2018

1 reference

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

21 January 2018

1 reference

Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis

21 January 2018

1 reference

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis

21 January 2018

1 reference

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis

21 January 2018

1 reference

High-dose acetylcysteine in idiopathic pulmonary fibrosis

21 January 2018

1 reference

Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis

21 January 2018

1 reference

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.

21 January 2018

1 reference

Nitric oxide synthases: structure, function and inhibition

21 January 2018

1 reference

Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro. Role of the epithelium

21 January 2018

1 reference

Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages

21 January 2018

1 reference

How to control NO production in cells: N(omega),N(omega)-dimethyl-L-arginine dimethylaminohydrolase as a novel drug target

21 January 2018

1 reference

The DDAH/ADMA/NOS pathway

21 January 2018

1 reference

Vascular endothelial cells synthesize nitric oxide from L-arginine

21 January 2018

1 reference

The DDAH-ADMA-NOS pathway

21 January 2018

1 reference

Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems

21 January 2018

1 reference

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

21 January 2018

1 reference

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

21 January 2018

1 reference

Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice

21 January 2018

1 reference

Nitric oxide and wound repair: role of cytokines?

21 January 2018

1 reference

The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis

21 January 2018

1 reference

Expression of nitric oxide synthase, aquaporin 1 and aquaporin 5 in rat after bleomycin inhalation.

21 January 2018

1 reference

Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury

21 January 2018

1 reference

In vivo characterization of the novel imidazopyridine BYK191023 [2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine], a potent and highly selective inhibitor of inducible nitric-oxide synthase

21 January 2018

1 reference

From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases

21 January 2018

1 reference

Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine

21 January 2018

1 reference

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

21 January 2018

1 reference

Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

21 January 2018

1 reference

The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough

21 January 2018

1 reference

The puzzle of endothelial nitric oxide synthase dysfunction in portal hypertension: The missing piece?

21 January 2018

1 reference

Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis

21 January 2018

1 reference

Emerging drugs for diabetic foot ulcers

21 January 2018

1 reference

Antifibrotic role of inducible nitric oxide synthase

21 January 2018

1 reference

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients

21 January 2018

1 reference

Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease

21 January 2018

1 reference

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis

21 January 2018

1 reference

Molecular Mechanism for Elevation of Asymmetric Dimethylarginine and Its Role for Hypertension in Chronic Kidney Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.4127

1 reference

27 August 2017

1 reference